Breaking News Instant updates and real-time market news.

RIG

Transocean

$8.54

-0.03 (-0.35%)

, RL

Ralph Lauren

$89.02

0.49 (0.55%)

10:39
08/09/17
08/09
10:39
08/09/17
10:39

On The Fly: Top five analyst upgrades

Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Transocean (RIG) upgraded to Neutral from Sell at Goldman Sachs with analyst Waqar Syed saying Transocean has enhanced the balance sheet over the past several months and now sees leveraged metrics to be relatively better than the peer group in the 2019/2020 time frame. 2. Ralph Lauren (RL) upgraded to Neutral from Underweight at Atlantic Equities. 3. Brink's (BCO) upgraded to Outperform from In-Line at Imperial Capital with analyst Jeff Kessler saying investors have "much to be bullish about" in the second half of 2017 following the company's "strong" first half results and recent acquisitions. 4. Novavax (NVAX) upgraded to Buy from Neutral at Ladenburg with analyst Kevin Degeeter saying he believes the company's NanoFlu could become a "potent vaccine" for prevention of seasonal influenza. 5. Esperion (ESPR) upgraded to Buy from Hold at Jefferies with analyst Michael Yee saying the shares are likely "to keep grinding higher and higher" following the "new de-risking data" for the triple combination. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.

RIG

Transocean

$8.54

-0.03 (-0.35%)

RL

Ralph Lauren

$89.02

0.49 (0.55%)

BCO

Brink's

$75.90

-0.65 (-0.85%)

NVAX

Novavax

$0.97

0.0111 (1.16%)

ESPR

Esperion

$52.13

6.96 (15.41%)

  • 10

    Aug

  • 29

    Aug

  • 26

    Sep

  • 10

    Aug

RIG Transocean
$8.54

-0.03 (-0.35%)

08/09/17
08/09/17
UPGRADE

Neutral
Transocean upgraded to Neutral on balance sheet improvements at Goldman Sachs
As previously reported, Goldman upgraded Transocean to Neutral from Sell and lowered its price target to $9.75 from $11.50. Analyst Waqar Syed said Transocean has enhanced the balance sheet over the past several months and now sees leveraged metrics to be relatively better than the peer group in the 2019/2020 timeframe.
07/06/17
BERN
07/06/17
NO CHANGE
BERN
'Global E&P investment to stall in 2018, ' says Bernstein
Bernstein analyst Colin Davies says that global investment in energy exploration and production will slow tremendously next year, falling about 2% globally and rising just 2% in the U.S. He says that E&Ps will have to reduce their rig count next year. In conjunction with the note, the analyst downgraded Noble Corp. (NE) to Underperform from Market Perform, downgraded Transocean (RIG) to Market Perform from Outperform, and downgraded Weatherford (WFT) to Market Perform from Outperform. He upgraded Schlumberger (SLB) to Outperform from Market Perform. Price target on Noble Corp to $2.50 from $7, on Transocean to $9 from $16.50, on Weatherford to $5 from $7, and on Schlumberger to $80 from $94.
07/06/17
BERN
07/06/17
DOWNGRADE
BERN
Market Perform
Transocean downgraded to Market Perform from Outperform at Bernstein
Bernstein analyst Colin Davies downgraded Transocean based on his belief that global investment in energy exploration and production will slow tremendously next year, falling about 2% globally and rising just 2% in the U.S. He says that E&Ps will have to reduce their rig count next year. Target to $9 from $16.50.
08/08/17
GSCO
08/08/17
UPGRADE
GSCO
Neutral
Transocean upgraded to Neutral from Sell at Goldman Sachs
RL Ralph Lauren
$89.02

0.49 (0.55%)

07/17/17
BUCK
07/17/17
INITIATION
Target $68
BUCK
Neutral
Ralph Lauren assumed with a Neutral at Buckingham
Buckingham analyst Eric Tracy assumed coverage of Ralph Lauren with a Neutral rating and $68 price target.
07/18/17
NEED
07/18/17
INITIATION
NEED
Hold
Ralph Lauren initiated with a Hold at Needham
08/09/17
ATLE
08/09/17
UPGRADE
ATLE
Neutral
Ralph Lauren upgraded to Neutral from Underweight at Atlantic Equities
08/09/17
UBSW
08/09/17
NO CHANGE
Target $90
UBSW
Neutral
Ralph Lauren price target raised to $90 from $73 at UBS
UBS analyst Michael Binetti raised his price target on Ralph Lauren following Q2 results but he said he is hesitant to take a more constructive stance on the shares with little visibility to a path back to positive revenue growth. However, he said even with yesterday's stock move, he doesn't think the shares are pricing in a potential for significant earnings upside. Binetti maintained his Neutral rating and raised his price target to $90 from $73 on Ralph Lauren shares.
BCO Brink's
$75.90

-0.65 (-0.85%)

11/28/16
GABE
11/28/16
DOWNGRADE
GABE
Hold
Brink's downgraded to Hold from Buy at Gabelli
02/27/17
RHCO
02/27/17
INITIATION
RHCO
Buy
Brink's initiated with a Buy at SunTrust
SunTrust analyst Tobey Sommer initiated Brink's with a Buy rating and a $62 price target, citing margin growth.
08/09/17
IMPC
08/09/17
UPGRADE
Target $86
IMPC
Outperform
Brink's upgraded to Outperform from In-Line at Imperial Capital
Imperial Capital analyst Jeff Kessler upgraded The Brink's Company to Outperform and raised his price target for the shares to $86 from $72. The analyst says investors have "much to be bullish about" in the second half of 2017 following the company's "strong" first half results and recent acquisitions.
12/12/16
MACQ
12/12/16
UPGRADE
MACQ
Outperform
Brink's upgraded to Outperform from Neutral at Macquarie
Macquarie analyst James Clement upgraded Brink's to Outperform and raised its price target to $50 from $38 citing relative valuation and new management's mandate to improve margins. The analyst expects Brink's can increase margins on a consolidated company wide basis by about 100bps annually and market share initiatives that could drive annual revenue growth of 5%.
NVAX Novavax
$0.97

0.0111 (1.16%)

12/16/16
CANT
12/16/16
INITIATION
Target $2
CANT
Neutral
Novavax initiated with a Neutral at Cantor
Cantor Fitzgerald analyst William Tanner started Novavax with a Neutral rating and $2 price target.
08/09/17
LTCO
08/09/17
UPGRADE
Target $1.6
LTCO
Buy
Novavax upgraded to Buy from Neutral at Ladenburg
Ladenburg Thalmann analyst Kevin Degeeter upgraded Novavax to Buy with a $1.60 price target. The analyst believes the company's NanoFlu could become a "potent vaccine" for prevention of seasonal influenza.
09/16/16
SBSH
09/16/16
DOWNGRADE
Target $1.5
SBSH
Neutral
Novavax downgraded to Neutral from Buy at Citi
Citi analyst Joel Beatty downgraded Novavax to Neutral after the company's RSV vaccine for older adults failed in Phase 3. The analyst does not expect results from the one remaining clinical trial until 2019. He cut his price target for the shares to $1.50 from $12. Four other firms downgraded Novavax this morning.
09/16/16
09/16/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. 21st Century Fox (FOX, FOXA) downgraded to Market Perform from Outperform at Bernstein with analyst Jason Park citing a reduction in his estimates for the company's Star India business. 2. Wells Fargo (WFC) downgraded to Underweight from Neutral at Atlantic Equities. 3. Citi (C) downgraded to Neutral from Buy at Goldman with analyst Richard Ramsden saying Citi's expected earnings inflection has failed to materialize and ROEs are at 7.7%, well below management's 10% target. 4. McCormick (MKC) downgraded to Market Perform from Outperform at Bernstein with analyst Alexia Howard citing valuation. 5. Novavax (NVAX) downgraded to Neutral from Overweight at Piper Jaffray, to Neutral from Overweight at JPMorgan, to Neutral from Buy at Ladenburg, to Neutral from Outperform at Wedbush, and to Neutral from Buy at Citi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
ESPR Esperion
$52.13

6.96 (15.41%)

08/08/17
JEFF
08/08/17
UPGRADE
JEFF
Buy
Esperion upgraded to Buy from Hold at Jefferies
08/08/17
NEED
08/08/17
NO CHANGE
Target $72
NEED
Buy
Esperion price target raised to $72 from $58 at Needham
Needham analyst Chad Messer raised Esperion's price target to $72 from $58 following positive triple combination data for bempedoic acid and improved regulatory timelines for filings. The analyst has a Buy rating on Esperion shares.
08/09/17
JEFF
08/09/17
UPGRADE
Target $85
JEFF
Buy
Esperion upgraded to Buy with $85 price target at Jefferies
Jefferies analyst Michael Yee last night upgraded Esperion Therapeutics to Buy from Hold and raised his price target for the shares to $85 from $55. The shares are likely "to keep grinding higher and higher" following the "new de-risking data" for the triple combination, Yee tells investors in a research note. The analyst sees potential partnership opportunities as a "big catalyst."
07/10/17
JEFF
07/10/17
INITIATION
Target $55
JEFF
Hold
Esperion initiated with a Hold at Jefferies
Jefferies initiated Esperion with a Hold and a $55 price target.

TODAY'S FREE FLY STORIES

CTL

CenturyLink

$19.72

-1.17 (-5.60%)

, LVLT

Level 3

$53.45

-1.73 (-3.14%)

13:13
08/17/17
08/17
13:13
08/17/17
13:13
Hot Stocks
CenturyLink says working to finalize Level 3 deal by end of Q3 »

CenturyLink (CTL) said in…

CTL

CenturyLink

$19.72

-1.17 (-5.60%)

LVLT

Level 3

$53.45

-1.73 (-3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CTL

CenturyLink

$19.73

-1.16 (-5.55%)

, LVLT

Level 3

$53.45

-1.73 (-3.14%)

13:12
08/17/17
08/17
13:12
08/17/17
13:12
Hot Stocks
Breaking Hot Stocks news story on CenturyLink, Level 3 »

CenturyLink says working…

CTL

CenturyLink

$19.73

-1.16 (-5.55%)

LVLT

Level 3

$53.45

-1.73 (-3.14%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ADP

ADP

$111.10

-0.48 (-0.43%)

13:10
08/17/17
08/17
13:10
08/17/17
13:10
Options
ADP attracts put buyers as shares come under fire »

ADP attracts put buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

ADOM

Adomani

$12.86

0.86 (7.17%)

, VLKAY

Volkswagen

$31.10

0.19 (0.61%)

13:06
08/17/17
08/17
13:06
08/17/17
13:06
Hot Stocks
Adomani sees $2.9B in settlement funds from Volkswagen »

Adomani (ADOM) announced…

ADOM

Adomani

$12.86

0.86 (7.17%)

VLKAY

Volkswagen

$31.10

0.19 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HZNP

Horizon Pharma

$11.89

-0.05 (-0.42%)

13:05
08/17/17
08/17
13:05
08/17/17
13:05
Options
Horizon Pharma call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CLS

Celestica

$11.50

-0.08 (-0.69%)

13:04
08/17/17
08/17
13:04
08/17/17
13:04
Upgrade
Celestica rating change  »

Celestica upgraded to Buy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDVX

Medovex

$0.95

0.05 (5.56%)

12:55
08/17/17
08/17
12:55
08/17/17
12:55
Hot Stocks
Medovex names Charlie Farrahar as CFO »

Medovex reported it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$33.20

-0.16 (-0.48%)

12:53
08/17/17
08/17
12:53
08/17/17
12:53
Hot Stocks
FDA posts approval of Pfizer's biologic license qpplication for Besponsa 

Reference Link

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Aug

  • 28

    Aug

  • 08

    Sep

  • 08

    Sep

  • 13

    Sep

NADL

North Atlantic Drilling

$1.44

-0.075 (-4.97%)

12:50
08/17/17
08/17
12:50
08/17/17
12:50
Options
Notable put spread in North Atlantic Drilling »

Notable put spread in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Aug

12:45
08/17/17
08/17
12:45
08/17/17
12:45
General news
Breaking General news story  »

Dallas Federal Reserve…

HRB

H&R Block

$30.21

-0.53 (-1.72%)

12:40
08/17/17
08/17
12:40
08/17/17
12:40
Options
Higher option volume in H&R Block driven by call buying »

Higher option volume in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Aug

  • 14

    Sep

EXPE

Expedia

$148.78

1.72 (1.17%)

12:35
08/17/17
08/17
12:35
08/17/17
12:35
Options
Expedia put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:35
08/17/17
08/17
12:35
08/17/17
12:35
General news
Treasury Option Action: call buying at the long-end »

Treasury Option Action:…

ADP

ADP

$111.10

-0.48 (-0.43%)

12:32
08/17/17
08/17
12:32
08/17/17
12:32
Hot Stocks
Chapman says making dollar going against Ackman feels as good as $10 »

Robert Chapman of Chapman…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

ADP

ADP

$111.10

-0.48 (-0.43%)

12:31
08/17/17
08/17
12:31
08/17/17
12:31
Hot Stocks
Breaking Hot Stocks news story on ADP »

Pershing Square's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

ADP

ADP

$111.10

-0.48 (-0.43%)

12:28
08/17/17
08/17
12:28
08/17/17
12:28
Hot Stocks
Breaking Hot Stocks news story on ADP »

Robert Chapman discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 11

    Sep

SPY

SPDR S&P 500 ETF Trust

$245.04

-1.9 (-0.77%)

, SPX

S&P 500

12:28
08/17/17
08/17
12:28
08/17/17
12:28
Technical Analysis
Technical View: S&P 500 hits lows of the day at midsession »

The S&P 500 (SPX) was…

SPY

SPDR S&P 500 ETF Trust

$245.04

-1.9 (-0.77%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WMT

Wal-Mart

$79.14

-1.84 (-2.27%)

, BABA

Alibaba

$166.91

7.4092 (4.65%)

12:25
08/17/17
08/17
12:25
08/17/17
12:25
General news
On The Fly: Top stock stories at midday »

Stocks opened in negative…

WMT

Wal-Mart

$79.14

-1.84 (-2.27%)

BABA

Alibaba

$166.91

7.4092 (4.65%)

AMZN

Amazon.com

$978.18

-4.56 (-0.46%)

AABA

Altaba

$60.65

0.66 (1.10%)

LB

L Brands

$35.15

-3.805 (-9.77%)

NTAP

NetApp

$42.41

0.44 (1.05%)

CSCO

Cisco

$32.34

0.25 (0.78%)

CTL

CenturyLink

$19.83

-1.06 (-5.07%)

LVLT

Level 3

$53.60

-1.58 (-2.86%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Aug

  • 17

    Aug

  • 17

    Aug

  • 18

    Aug

  • 23

    Aug

  • 24

    Aug

  • 06

    Sep

  • 06

    Sep

  • 14

    Sep

  • 16

    Nov

  • 20

    Feb

HST

Host Hotels

$18.33

0.095 (0.52%)

12:20
08/17/17
08/17
12:20
08/17/17
12:20
Options
Hefty call spread in Host Hotels as a position is adjusted »

Hefty call spread in Host…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GM

General Motors

$35.35

-0.4 (-1.12%)

12:19
08/17/17
08/17
12:19
08/17/17
12:19
Periodicals
GM creditor cancels settlement with ignition switch plaintiffs, Reuters says »

A trust that holds many…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

12:17
08/17/17
08/17
12:17
08/17/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

12:16
08/17/17
08/17
12:16
08/17/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

JMBA

Jamba

$9.11

-0.35 (-3.70%)

12:15
08/17/17
08/17
12:15
08/17/17
12:15
Hot Stocks
Jamba trades higher after Indus capital reports new stake, says undervalued »

Indus Capital reported…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HRG

HRG Group

$15.78

-0.075 (-0.47%)

12:10
08/17/17
08/17
12:10
08/17/17
12:10
Options
Second day of interest in HRG Group in the money calls »

Second day of interest in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

MDXG

MiMedx

$16.93

0.19 (1.14%)

12:07
08/17/17
08/17
12:07
08/17/17
12:07
Hot Stocks
MiMedx updates on litigation with terminated employees »

MiMedx Group provided an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

  • 14

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.